We provide you with 20 years of free, institutional-grade data for URGN stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of URGN. Explore the full financial landscape of URGN stock.
Reported Date | CIK | Ticker | Type | |
---|---|---|---|---|
2025-08-07 | 1668243 | URGN | 10-Q | Url |
2025-05-12 | 1668243 | URGN | 10-Q | Url |
2025-03-10 | 1668243 | URGN | 10-K | Url |
2024-11-06 | 1668243 | URGN | 10-Q | Url |
2024-08-13 | 1668243 | URGN | 10-Q | Url |
2024-05-13 | 1668243 | URGN | 10-Q | Url |
2024-03-14 | 1668243 | URGN | 10-K | Url |
2023-11-14 | 1668243 | URGN | 10-Q | Url |
2023-08-10 | 1668243 | URGN | 10-Q | Url |
2023-05-11 | 1668243 | URGN | 10-Q | Url |
2023-03-24 | 1668243 | URGN | 10-K | Url |
2022-11-10 | 1668243 | URGN | 10-Q | Url |
2022-08-11 | 1668243 | URGN | 10-Q | Url |
2022-05-10 | 1668243 | URGN | 10-Q | Url |
2022-03-21 | 1668243 | URGN | 10-K | Url |
2021-11-15 | 1668243 | URGN | 10-Q | Url |
2021-08-04 | 1668243 | URGN | 10-Q | Url |
2021-05-13 | 1668243 | URGN | 10-Q | Url |
2021-03-18 | 1668243 | URGN | 10-K | Url |
2020-11-09 | 1668243 | URGN | 10-Q | Url |
2020-08-10 | 1668243 | URGN | 10-Q | Url |
2020-05-07 | 1668243 | URGN | 10-Q | Url |
2020-03-02 | 1668243 | URGN | 10-K | Url |
2019-11-12 | 1668243 | URGN | 10-Q | Url |
2019-08-09 | 1668243 | URGN | 10-Q | Url |
2019-05-09 | 1668243 | URGN | 10-Q | Url |
2019-02-28 | 1668243 | URGN | 10-K | Url |
2018-11-13 | 1668243 | URGN | 6-K | Url |
2018-10-31 | 1668243 | URGN | 6-K | Url |
2018-10-01 | 1668243 | URGN | 6-K | Url |
2018-09-21 | 1668243 | URGN | 6-K | Url |
2018-09-18 | 1668243 | URGN | 6-K | Url |
2018-08-30 | 1668243 | URGN | 6-K | Url |
2018-08-14 | 1668243 | URGN | 6-K | Url |
2018-08-08 | 1668243 | URGN | 6-K | Url |
2018-07-13 | 1668243 | URGN | 6-K | Url |
2018-06-06 | 1668243 | URGN | 6-K | Url |
2018-06-06 | 1668243 | URGN | 6-K | Url |
2018-05-15 | 1668243 | URGN | 6-K | Url |
2018-04-25 | 1668243 | URGN | 6-K | Url |
2018-04-04 | 1668243 | URGN | 6-K | Url |
2018-03-16 | 1668243 | URGN | 6-K | Url |
2018-03-15 | 1668243 | URGN | 20-F | Url |
2018-02-20 | 1668243 | URGN | 6-K | Url |
2018-02-14 | 1668243 | URGN | 6-K | Url |
2018-01-11 | 1668243 | URGN | 6-K | Url |
2018-01-08 | 1668243 | URGN | 6-K | Url |
2017-12-14 | 1668243 | URGN | 6-K | Url |
2017-11-14 | 1668243 | URGN | 6-K | Url |
2017-11-07 | 1668243 | URGN | 6-K | Url |
2017-11-02 | 1668243 | URGN | 6-K | Url |
2017-08-29 | 1668243 | URGN | 6-K | Url |
2017-08-14 | 1668243 | URGN | 6-K | Url |
2017-07-19 | 1668243 | URGN | 6-K | Url |
2017-05-18 | 1668243 | URGN | 6-K | Url |
UroGen Pharma Ltd(NASDAQ:URGN)

UroGen Pharma Ltd., a biopharmaceutical company, engages in the development and commercialization novel solutions for specialty cancers and urologic diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmy...
Website: http://www.urogen.com
Founded: 2004
Full Time Employees: 187
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about URGN stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.